Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details Narrative)

v3.21.2
ACQUISITIONS (Details Narrative)
1 Months Ended 9 Months Ended
Dec. 31, 2019
USD ($)
Sep. 30, 2021
USD ($)
ft²
shares
Aug. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
ft²
shares
Sep. 30, 2021
USD ($)
ft²
Dec. 31, 2020
USD ($)
Oct. 31, 2019
ft²
Dec. 21, 2018
Dec. 31, 2016
Business Acquisition [Line Items]                  
Area of land | ft²   300,000     300,000        
Common Stock, Value, Issued   $ 331,545     $ 331,545 $ 314,419      
Members Kind Therapeutics USA Inc [Member]                  
Business Acquisition [Line Items]                  
Equity onwership percentage                 30.00%
The Harvest Foundation LLC [Member]                  
Business Acquisition [Line Items]                  
Percentage of interests acquired in business acquisition     100.00%            
The Harvest Foundation LLC [Member] | Two Owners [Member]                  
Business Acquisition [Line Items]                  
Sale of stock, shares | shares     1,000,000            
Sale of stock, value     $ 1,200,000            
Warrants to purchase shares | shares     400,000            
Kind Therapeutics USA Inc. [Member]                  
Business Acquisition [Line Items]                  
Percentage of interests acquired in business acquisition               100.00%  
Equity onwership percentage                 70.00%
Payment for business acquisition       $ 6,300,000          
Stock issued during period, shares, acquisitions | shares       2,500,000          
Lessor, operating lease, term of contract       20 years          
Area of land | ft²       180,000          
Kind Therapeutics USA Inc. [Member] | Anne Arundel County, MD [Member]                  
Business Acquisition [Line Items]                  
Area of land | ft²             9,000    
Meditaurus LLC [Member]                  
Business Acquisition [Line Items]                  
Sale of stock, shares | shares   100,000              
Equity onwership percentage 70.00% 30.00%     30.00%        
Payment for business acquisition $ 2,800,000                
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Fair Value Method         The Company currently sells CBD products developed by MediTaurus under its Florance™ brand        
Common Stock, Value, Issued   $ 94,000     $ 94,000        
Dividends, Common Stock, Cash   10,000              
Noncontrolling Interest, Increase from Business Combination   $ 975,000